"Das Marien-Hospital ist ein leistungsfähiges Krankenhaus mit 1.000 Mitarbeitern. Das Haus verfügt über 432 Betten und 16 Fachabteilungen. Jährlich werden etwa 20.000 Patienten stationär und fast 50.000 ambulant behandelt. Dies geschieht nach Diagnose-, Therapie- und Operationsverfahren auf dem Stand von Wissenschaft und Technik. Im Sinne einer qualitätsgesicherten Versorgung in Medizin und Pflege ist das Marien-Hospital nach DIN EN ISO 9001 zertifiziert. Die Zusammenarbeit mit wissenschaftlichen Exzellenz-Zentren im In- und Ausland ermöglicht Patienten den Zugang zu internationaler Spitzenmedizin. Durch seine fachliche Expertise hat sich das Hospital einen guten Ruf als Maximalversorger am Niederrhein und darüber hinaus erworben."

During the past decade, Marien-Hospital Wesel gGmbH conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Marien-Hospital Wesel gGmbH" #1 sponsor was "Marien Hospital Wesel" with 2 trials, followed by "Airsonett AB" with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "Heinrich-Heine University, Duesseldorf" with 1 trials sponsored and "Infectopharm Arzneimittel GmbH" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Marien-Hospital Wesel gGmbH" #1 collaborator was "Commitum AB" with 1 trials as a collaborator, "Croel AB" with 1 trials as a collaborator, "Gesellschaft für Therapieforschung mbH" with 1 trials as a collaborator, "Hannover Medical School" with 1 trials as a collaborator and "Heinrich-Heine University, Duesseldorf" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Marien-Hospital Wesel gGmbH" are "Asthma" (2 trials), "Atopic Dermatitis" (1 trials), "Atrial Fibrillation" (1 trials), "Breast Cancer" (1 trials) and "Healthy" (1 trials). Many other conditions were trialed in "Marien-Hospital Wesel gGmbH" in a lesser frequency.

Most popular intervention types in "Marien-Hospital Wesel gGmbH" are "Drug" (4 trials), "Biological" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Aspirin" (1 trials), "Clopidogrel or Ticagrelor" (1 trials), "Dabigatran Etexilate 110mg" (1 trials), "Dabigatran Etexilate 150mg" (1 trials) and "HGT-1110" (1 trials). Other intervention names were less common.

The vast majority of trials in "Marien-Hospital Wesel gGmbH" are 6 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Marien-Hospital Wesel gGmbH". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Marien-Hospital Wesel gGmbH, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Marien-Hospital Wesel gGmbH, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".